Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
2024 China Drug Discovery Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 India Drug Discovery Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 France Drug Discovery Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
Global Herpes Zoster Therapeutics Market 2024-2028
... period. The report on the herpes zoster therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Global Antiplatelet Market: Analysis By Drug Class (Adenosine Diphosphate Receptor Inhibitors, Irreversible Inhibitors Cyclooxygenase, and Other Drug Classes), By Route of Administration (Oral and Injectable), By Distribution Channel (Drug Stores, Hospital Pharmacies, and Online Stores), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
... By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029 - Report Summary Report Metrics Details Years Considered 2019-2029 Base Year 2023 Forecast Period 2024-2029 Page Count 146 Units Referenced US ... Read More
-
Genomics Market by Product (Kits, Consumables, Instruments), Services (Bioinformatics), Technology (Sequencing, PCR, ISH), Study Type (Epigenomics, Functional Genomics), Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2029
... USD 66.85 billion in 2029 from USD 42.64 billion in 2024, at a CAGR of 9.4% during the forecast period. Growth in the genomics market is mainly driven by factors like expanding genomic studies to ... Read More
-
Artificial Intelligence in Drug Discovery Market by Process (Target, Lead), Use Case (Design & Optimisation: Vaccine, Antibody; Disease understanding, PK/PD), Therapy (Cancer, CNS, CVS), Tool (ML:DL (CNN, GAN)), End User & Region - Global Forecast to 2029
... to 2029 The global artificial intelligence (AI) in drug discovery market is projected to reach 6.89 billion by 2029 from 1.86 billion in 2024, at a CAGR of 29.9% from 2024 to 2029. Increasing cross-industry ... Read More
-
Global Drug Discovery Technology Market 2024-2028
... period. The report on the drug discovery technology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Global Irritable Bowel Syndrome Market 2024-2028
... period. The report on the irritable bowel syndrome market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Global Prils Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Anti-venom Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Non-Small Cell Lung Cancer (NSCLC) Therapeutics – A Global Market Overview
... spreading more slowly than small cell lung cancer. The primary subtypes of NSCLC include adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Adenocarcinoma, often located in the outer regions of the lung, accounts for about ... Read More
-
Lung Cancer Therapeutics – A Global Market Overview
... genetic damage to airway cells from smoking or exposure to harmful chemicals. This uncontrolled cell growth results in the formation of tumors, which can hinder lung function. Early-stage lung cancer often shows no symptoms and ... Read More
-
Strategic Intelligence: AI in drug discovery
... pharma value chain. Artificial intelligence (AI) and big data are at the forefront of driving innovation, from enhancing drug discovery to optimizing clinical trial design. The drug discovery process is a very expensive and time-consuming ... Read More
-
Head and Neck Cancer Therapeutics – A Global Market Overview
... the head and neck, including the lips, oral cavity (mouth), nasal cavity, pharynx (throat), larynx (voice box), salivary glands, and paranasal sinuses. These cancers are squamous cell carcinomas that usually begin from the flat cells ... Read More
-
Breast Cancer Therapeutics – A Global Market Overview
... invade nearby tissues or spread to other parts of the body. It is the most common cancer diagnosed in women, although it can also affect men, and the second most common cause of death from ... Read More
-
Exocrine Pancreatic Insufficiency Treatment Market
... by a lack of pancreatic enzymes critical for nutrient digestion and absorption, is managed through a combination of medical and dietary approaches. Treatment strategies for EPI aim to reduce symptoms, boost nutrient absorption, and improve ... Read More
-
Non-animal Alternative Testing Market
... by rising investments and research grants advancing alternative testing methods. Heightened ethical concerns surrounding animal testing, alongside regulatory initiatives from agencies such as the U.S. FDA and European Union, have accelerated the shift toward humane ... Read More
-
2025 Global: Vaccines For Human Medicine (Excl. Vaccines Against Sars-Related Coronaviruses) Products-Manufacturing Forecast (2031) report
... projected growth/decline and regional data for the period 2020 through 2031. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and ... Read More
-
Small Molecule Drug Discovery Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Orthopedics, Immunology, Rare Diseases, and Other Therapeutic Areas), Process/Phase (Target Discovery, Target Validation, Lead Generation and Refinement, and Preclinical Development), and Geography
... and Other Therapeutic Areas), Process/Phase (Target Discovery, Target Validation, Lead Generation and Refinement, and Preclinical Development), and Geography The Small Molecule Drug Discovery market is anticipated to grow from US$ 50.93 billion in 2023 and ... Read More
-
Al in Pathology Market by Neural Network (GAN, CNN, RNN), Function (Diagnostic, Image Analysis, CDSS, Data Management, Analytics), Use Case (Drug Discovery, Clinical workflow), End User (Hospital, Labs, Pharma/Biotech), & Region - Global Forecast to 2029
... 2029 The global AI in Pathology market is expected to reach USD 169.8 million by 2029 from USD 82.8 million in 2024 at a high CAGR of 15.4% during the forecast period. AI in pathology ... Read More
-
Endocrinology Drugs Market by Therapy Area (Adrenal Insufficiency, Diabetes, Growth Hormone Disorders, Other Therapy Areas), Drug Class, Distribution Channel, and Geography - Global Industry Analysis, Opportunities and Forecast up to 2030
... The global endocrinology drugs market size was valued at $98.31 billion in 2024 and is projected to reach $145.89 billion by 2030, growing at a CAGR of 6.8% during the forecast period. Endocrinology Drugs Market ... Read More
-
Dermatology Drugs Market by Type (Cosmetic Dermatology, Cutaneous Lymphoma, Other Types), Route of Administration, Indication, Distribution Channel, End User, and Geography - Global Industry Analysis, Opportunities and Forecast up to 2030
... The global dermatology drugs market size was valued at $33.39 billion in 2024 and is projected to reach $62.45 billion by 2030, growing at a CAGR of 11.0% during the forecast period. Dermatology Drugs Market ... Read More
-
Pemphigus Vulgaris (PV) - Market Insight, Epidemiology And Market Forecast - 2034
... ~15 million cases were diagnosed, and this number is projected to increase by the end of 2034 in the 7MM. In 2023, the market size of metabolic dysfunction-associated steatohepatitis (MASH) was highest in the US ... Read More
-
Metabolic Disorder Therapeutics
... by 2030, growing at a CAGR of 6.8% over the analysis period 2023-2030. Diabetes Therapeutics, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$91.9 Billion by ... Read More